Grand mal Generalized tonic-clonic seizure Completed Phase 4 Trials for Levetiracetam (DB01202)

Also known as: Tonic-clonic Seizure / Grand mal seizure / Primary generalized tonic-clonic seizures / Generalized tonic-clonic Seizure / Grand mal Seizures / Seizures, Tonic-Clonic / Generalised tonic-clonic seizures / Centrencephalic epilepsies / Primary Generalized tonic-clonic seizure / Generalized Tonic-Clonic Seizures / Seizure grand mal / Generalised tonic-clonic seizure / Generalized tonic clonic seizure / Generalized Tonic Clonic Seizures / Tonic-clonic seizures / Centrencephalic epilepsy / Generalised onset motor seizure / Generalized onset motor seizure / Grand mal seizure (finding) / Tonic-clonic seizure (finding) / Epilepsy with grand mal seizures on awakening / Grand mal fit / Grand mal epileptic fit / Centrencephalic epilepsy (disorder)

DBCOND0021730 (Grand mal Generalized tonic-clonic seizure)Completed4 IdentifierTitlePurposeDrugs
NCT00510783IV Keppra in the Emergency Department for Prevention of Early Recurrent SeizuresTreatment